Interpretation of clinical diagnosis and treatment consensus of pulmonary sarcoidosis by British Thoracic Society (BTS)
10.3760/cma.j.cn431274-20210713-00747
- VernacularTitle:英国胸科协会肺结节病临床诊治共识解读
- Author:
Zijing ZHOU
1
;
Hong PENG
Author Information
1. 中南大学湘雅二医院呼吸与危重症医学科，长沙 410011
- Keywords:
Sarcoidosis, pulmonary;
Clinical statement;
British thoracic society
- From:
Journal of Chinese Physician
2021;23(8):1121-1127
- CountryChina
- Language:Chinese
-
Abstract:
Sarcoidosis is a granulomatous disease of unknown etiology that affects almost any organ. The clinical presentation, treatment responsiveness and outcome varies widely between patients. Patients with pulmonary sarcoidosis always need individualized treatment and should be monitored. In order to meet the above clinical needs, countries have successively formulated clinical diagnosis and treatment norms of sarcoidosis. This includes the clinical consensus on pulmonary sarcoidosis (BTS consensus) launched by the British Thoracic Society (BTS) in December 2020. This paper briefly describes the main parts of the BTS consensus to provide reference for the majority of clinical workers.
